P-104 SECURE: An Observational Study of Certolizumab Pegol in Crohnʼs Disease—Events of Interest Analysis with 5869 Patient-Years at Risk
2016
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI